OM:BINVBiotechs
BioInvent International Q1 2026 Losses Deepen Concerns Around Longstanding Unprofitable Narrative
BioInvent International (OM:BINV) has just put out its Q1 2026 scorecard, and recent history shows a business with highly variable revenue and EPS, ranging from 22.06 million SEK in Q1 2025 with EPS of 1.77 SEK loss to 198.10 million SEK in Q2 2025 with EPS of 0.59 SEK and back to 3.02 million SEK in Q4 2025 with EPS of 1.91 SEK loss, with trailing twelve month EPS at 5.06 SEK loss on 226.50 million SEK of revenue. Over that stretch, net income has swung between a 38.80 million SEK profit and...